USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke ATRECA wurde als Wortmarke am 23.03.2011 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - NO STATEMENT OF USE FILED".
| Markenform | Wortmarke |
| Aktenzeichen | 85275010 |
| Anmeldedatum | 23. März 2011 |
| Veröffentlichungsdatum | 16. Oktober 2012 |
Markeninhaber
500 Saginaw Dr., Suite 100
94063 Redwood City
US
94063 Redwood City
US
Markenvertreter
Waren und Dienstleistungen
1
Diagnostic preparations and diagnostic kits comprised of buffers and reagents for clinical, medical laboratory, or research use, for predicting the response of patients to therapeutics; biological tissue for research and scientific diagnosis use; antibodies for research and scientific diagnosis use; combinations of biological tissue for research and scientific diagnosis use; combinations of antibodies for research and scientific diagnosis use; kits containing buffers and chemical reagents for use in molecular biology research applications
5
Diagnostic preparations and diagnostic kits comprised of buffers and reagents for medical use, for predicting the response of patients to therapeutics; biologics for medical use, namely, biological preparation for the treatment of infectious disease; biologics for medical use, namely, biological preparation for the treatment of cancer; biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; biologics for medical use, namely, biological preparation for the treatment of animal health; biologics, namely, biological tissue for medical diagnosis; biologics, namely, antibodies for medical diagnosis; biologics, namely, vaccines for medical diagnosis, research and scientific diagnosis; combinations of biologics for medical use, namely, biological preparation for the treatment of infectious disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cancer; combinations of biologics for medical use, namely, biological preparation for the treatment of autoimmune disease; combinations of biologics for medical use, namely, biological preparation for the treatment of cardiovascular disease; combinations of biologics for medical use, namely, biological preparation for the treatment of animal health; combinations of biologics, namely, biological tissue, antibodies, and vaccines, for medical diagnosis
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1385275010